Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 117


Respiratory syncytial virus G protein and G protein CX3C motif adversely affect CX3CR1+ T cell responses.

Harcourt J, Alvarez R, Jones LP, Henderson C, Anderson LJ, Tripp RA.

J Immunol. 2006 Feb 1;176(3):1600-8.


CX3C chemokine mimicry by respiratory syncytial virus G glycoprotein.

Tripp RA, Jones LP, Haynes LM, Zheng H, Murphy PM, Anderson LJ.

Nat Immunol. 2001 Aug;2(8):732-8.


The chemokine receptor CX3CR1 controls homing and anti-viral potencies of CD8 effector-memory T lymphocytes in HIV-infected patients.

Combadière B, Faure S, Autran B, Debré P, Combadière C.

AIDS. 2003 Jun 13;17(9):1279-90.


CD4(+) T-cell-mediated antiviral protection of the upper respiratory tract in BALB/c mice following parenteral immunization with a recombinant respiratory syncytial virus G protein fragment.

Plotnicky-Gilquin H, Robert A, Chevalet L, Haeuw JF, Beck A, Bonnefoy JY, Brandt C, Siegrist CA, Nguyen TN, Power UF.

J Virol. 2000 Apr;74(8):3455-63.


Infection of mice with respiratory syncytial virus during neonatal life primes for enhanced antibody and T cell responses on secondary challenge.

Tasker L, Lindsay RW, Clarke BT, Cochrane DW, Hou S.

Clin Exp Immunol. 2008 Aug;153(2):277-88. doi: 10.1111/j.1365-2249.2008.03591.x. Epub 2008 Jun 28.


Vaccination to induce antibodies blocking the CX3C-CX3CR1 interaction of respiratory syncytial virus G protein reduces pulmonary inflammation and virus replication in mice.

Zhang W, Choi Y, Haynes LM, Harcourt JL, Anderson LJ, Jones LP, Tripp RA.

J Virol. 2010 Jan;84(2):1148-57. doi: 10.1128/JVI.01755-09. Epub 2009 Oct 28.


Respiratory syncytial virus G protein CX3C motif impairs human airway epithelial and immune cell responses.

Chirkova T, Boyoglu-Barnum S, Gaston KA, Malik FM, Trau SP, Oomens AG, Anderson LJ.

J Virol. 2013 Dec;87(24):13466-79. doi: 10.1128/JVI.01741-13. Epub 2013 Oct 2.


Migration of CX3CR1-positive T cells producing type 1 cytokines and cytotoxic molecules into the synovium of patients with rheumatoid arthritis.

Nanki T, Imai T, Nagasaka K, Urasaki Y, Nonomura Y, Taniguchi K, Hayashida K, Hasegawa J, Yoshie O, Miyasaka N.

Arthritis Rheum. 2002 Nov;46(11):2878-83.


Nanoparticle vaccines encompassing the respiratory syncytial virus (RSV) G protein CX3C chemokine motif induce robust immunity protecting from challenge and disease.

Jorquera PA, Choi Y, Oakley KE, Powell TJ, Boyd JG, Palath N, Haynes LM, Anderson LJ, Tripp RA.

PLoS One. 2013 Sep 10;8(9):e74905. doi: 10.1371/journal.pone.0074905. eCollection 2013.


Increased pathogenesis and inflammation of airways from respiratory syncytial virus infection in T cell deficient nude mice.

Zhou J, Yang XQ, Fu Z, Zhao XD, Jiang LP, Wang LJ, Cui YX.

Med Microbiol Immunol. 2008 Dec;197(4):345-51. Epub 2007 Dec 5.


Effect of chemokine receptor CX3CR1 deficiency in a murine model of respiratory syncytial virus infection.

Johnson CH, Miao C, Blanchard EG, Caidi H, Radu GU, Harcourt JL, Haynes LM.

Comp Med. 2012 Feb;62(1):14-20.


Fractalkine and CX3CR1 are involved in the recruitment of intraepithelial lymphocytes of intrahepatic bile ducts.

Isse K, Harada K, Zen Y, Kamihira T, Shimoda S, Harada M, Nakanuma Y.

Hepatology. 2005 Mar;41(3):506-16.

Items per page

Supplemental Content

Write to the Help Desk